news image
forbes.com | Sept. 8, 2022, 3:35 p.m.

Revance Shares Jump 18% After FDA Approves Botox Rival Daxxify

| Revance shares jump
Read more
#Trending News for the last 24 Hrs
RAHUL GANDHI MANGALURU PARLIAMENT HATHRAS INDIA BJP PM MUMBAI WAYANAD SEBI ADANI MALAPPURAM KANNUR AAP CPM ASSAM MODI NEET U.S. TRANSPORT